Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yilan Yan"'
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Background Neonatal nurses should provide timely and high-quality palliative care whenever necessary. It’s necessary to investigate the knowledge, attitude and behavior of palliative care among neonatal nurses, to provide references and ev
Externí odkaz:
https://doaj.org/article/49d71869aa9644ec947b0979d7eaadc1
Publikováno v:
Urban, Planning and Transport Research, Vol 11, Iss 1 (2023)
ABSTRACTMa’anshan City, located in the Yangtze River Delta region, is a demonstration city for handling the industrial transfer of the Nanjing, Hefei, and Wanjiang Metropolitan Areas in China. Developing and utilizing underground space can effectiv
Externí odkaz:
https://doaj.org/article/1a31e91f54ff4eff837b57c0b352efcd
Publikováno v:
Journal of Computational and Theoretical Nanoscience. 13:10364-10368
Publikováno v:
Geoinformatics
Rock tunnel is a kind of large-scale infrastructure with long-term investment cycle and complex technologies, involving a number of participants. Aiming at a large number of hydrogeological data in the project, establishing a standard description of
Autor:
Xinxin Rao, Xuanyi Wang, Kairui Jin, Yilan Yang, Xu Zhao, Zhe Pan, Weiluo Lv, Zhen Zhang, Li Zhang, Xiaoli Yu, Xiaomao Guo
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Aim The objective of this study is to comprehensively evaluate the therapeutic efficacy of postmastectomy radiotherapy (PMRT) in treating patients with pT3N0‐1M0 breast cancer within the context of modern therapeutic strategies. Methods Cl
Externí odkaz:
https://doaj.org/article/55d8f89fdf1643379daaef7cc9f231ce
Autor:
Yu Zhong, Min Jiang, Yunshi Wang, Tingting Su, Yuanzhi Lv, Zhiqing Fan, Hengyi Ning, Yilan Yang, Yanhua Chen, Yubo Xie
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Flexible fiberoptic bronchoscopy (FFB) for children is widely performed under sedation. Currently, the optimal sedation regimen remains unclear. Esketamine is an N-methyl-D-aspartic acid (NMDA) receptor antagonist, which has stronger seda
Externí odkaz:
https://doaj.org/article/778efc50ff1f405bb3035c79cdd87999
Autor:
Yilan Yang, Xu Zhao, Xuanyi Wang, Kairui Jin, Jurui Luo, Zhaozhi Yang, Xin Mei, Jinli Ma, Zhimin Shao, Zhen Zhang, Xingxing Chen, Xiaomao Guo, Xiaoli Yu
Publikováno v:
Cancer Medicine, Vol 11, Iss 14, Pp 2755-2766 (2022)
Abstract Purpose Currently, the prognostic value of molecular subtypes in ductal carcinoma in situ (DCIS) remains unclear. In this study, we explored whether molecular subtypes could predict second breast events (SBEs) in patients after breast‐cons
Externí odkaz:
https://doaj.org/article/3a243123608341bea894d38d0f56cfd5
Autor:
Nan Wu, Lian Zhang, Minglong Chen, Qi Wan, Zidun Wang, Fengming Wu, Xiaoyuan Gao, Yilan Yang, Mingfang Li
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Objectives The initial medical contact of patients with atrial fibrillation (AF) and ischaemic stroke is often performed by neurologists. However, when stand care with oral anticoagulants (OACs) adherence and persistence was emphasised by cardiologis
Externí odkaz:
https://doaj.org/article/4c34e301681046ecb1caca5991ff6451
Autor:
Chunyan Li, Yilan Yang, Jiangfeng Wang, Kairui Jin, Zhaozhi Yang, Xiaoli Yu, Xiaomao Guo, Xingxing Chen
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7203-7212 (2021)
Abstract Background Ductal carcinoma in situ with microinvasion (DCISM) represents ~1% of all breast cancer cases and is arguably a more aggressive subtype of ductal carcinoma in situ (DCIS). Lacking studies with a large population, the survival outc
Externí odkaz:
https://doaj.org/article/52cd27b5234b42788c45e024e4df4354
Autor:
Yilan Yang, Jurui Luo, Xingxing Chen, Zhaozhi Yang, Xin Mei, Jinli Ma, Zhen Zhang, Xiaomao Guo, Xiaoli Yu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-11 (2020)
Abstract Recently, the focus of enhancing tumor radiosensitivity has shifted from chemotherapeutics to targeted therapies. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are a novel class of selective cell cycle therapeutics that target the cycl
Externí odkaz:
https://doaj.org/article/0d4c835d29944cecb74f0ee9d612a8b5